07.04.2010 • News

Akzo Nobel Rebrands Indian ICI business

Akzo Nobel's integration activities following the acquisition of ICI have reached a significant landmark with the ICI India business now officially known as Akzo Nobel India Limited. ICI India, a separate listed company on the stock market, is one of the country's leading decorative paints businesses. Led by Managing Director Amit Jain under the same Board of Directors, the rebranded business will continue to play a pivotal role in the company's strategic growth plans.

"We are delighted that ICI India has now officially taken on the AkzoNobel name," said CEO Hans Wijers. "India is a very important market for us and we are now well prepared to take full advantage of the world class capabilities of our Indian decorative paints organization and build on our promising market position."

He added that AkzoNobel plans to make major investments in India during the next five years to boost the opportunities in this high-growth market. "The change in identity is just the beginning of a wave of strategic investments which we plan to make in people, practices, new ways of marketing, technology and research," continued Wijers.

Company

Logo:

AkzoNobel

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read